# Auron Therapeutics, Inc.: Biotechnology, Newton, United States

> Auron Therapeutics, Inc.: Auron Therapeutics, Inc. Based in Newton, United States. Founded 2018. What Millionrounds holds on them, and what we have not seen.

Source: https://millionrounds.com/startup/auron-therapeutics-inc (Millionrounds; every figure on the page links to its filing or article)

United States · [Biotechnology startup](https://millionrounds.com/companies)

# Auron Therapeutics, Inc.

Auron Therapeutics, Inc.

Funding reported Last round: Series B

Biotechnology Newton, United States

Company summary

- **Founded:** 2018 8 years old
- **Team:** 20 11 to 50 people
- **Funding reported:** $91M in dollars
- **Last round:** Series B Feb 2025

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Auron Therapeutics, Inc. has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Auron Therapeutics, Inc.

Auron Therapeutics, Inc.

is a clinical-stage biotechnology company based in Newton, Massachusetts. Founded by Dr. Kate Yen, Ph.D., the company focuses on developing first-in-class targeted therapies that utilize cell-state plasticity to transform malignant cells into normal, functioning cells. Auron's mission is to cure cancer by reactivating cellular programs that promote tumor cell maturation and differentiation. The company’s proprietary AURIGINTM platform employs AI and machine learning to analyze cell states and identify novel drug targets. Auron is advancing its lead candidate, AUTX-703, an oral KAT2A/B degrader, which has received FDA clearance for Phase 1 clinical development in hematological malignancies, specifically acute myeloid leukemia. Auron aims to build a pipeline of differentiation therapies that reprogram cancer cells, targeting both solid tumors and hematologic malignancies, as well as addressing inflammatory diseases.

## What company datasets say Auron Therapeutics, Inc. raised

Funding, as reported

Reported in all **$91M** in dollars

Last round **Series B**

Last round size **$27M**

Last round date **Feb 2025**

Investors listed **4**

## The company, in detail

What they build

Known for

health care tumor microenvironment oncology aurigin platform first-in-class drugs healthcare drug resistance cancer therapy biomarker identification epigenetic therapy epigenetic regulators autx-703 multi-omics data biotech platform pharmaceuticals targeted therapy

Built with from their website

Google Maps Zendesk KnowBe4 CloudFlare CDN Google Tag Manager Amazon CloudFront Google Hosted Libraries Google Font API HSTS Microsoft Exchange

+8 more

Microsoft 365 Cloudflare DNS Outlook Zoom Meetings reCAPTCHA CloudFlare Microsoft 365 Apps & Services Viewport Meta

- **Sector:** Biotechnology
- **Industry code:** NAICS 541714, SIC 2834, 8731
- **Region:** Massachusetts
- **Revenue:** $3.6M a year, as listed

## Biotechnology in United States

Startups like it

- [**National Resilience** founded 2020 *Raised*](https://millionrounds.com/company/national-resilience)
- [**CREATE Medicines** Cambridge · founded 2019 *Raised*](https://millionrounds.com/company/create-medicines)
- [**AusperBio Therapeutics** Startup *Raised*](https://millionrounds.com/company/ausperbio-therapeutics)
- [**City Therapeutics** Startup *Raised*](https://millionrounds.com/company/city-therapeutics)
- [**Nohla Therapeutics** Seattle · founded 2015 *Raised*](https://millionrounds.com/company/nohla-therapeutics)
- [**Genapsys** Redwood City · founded 2010 *Raised*](https://millionrounds.com/company/genapsys)
- [**Proxima Bio** Startup *Raised*](https://millionrounds.com/company/proxima-bio)
- [**Infinimmune** Alameda · founded 2022 *Raised*](https://millionrounds.com/company/infinimmune)

## Is this your company?

Add your raise, your deck and your story, and put Auron Therapeutics, Inc. in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)